Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.35 | -15.27 |
| PEG Ratio (TTM) | -0.27 | -4.35 |
| P/S Ratio (TTM) | 59.23 | 45.97 |
| P/B Ratio (TTM) | 0.86 | 28.96 |
| P/FCF Ratio (TTM) | -1.41 | -2.59 |
| Price to 5YR AVG Earnings Ratio | -1.08 | -5.56 |
| Price to 5YR AVG FCF Ratio | -1.33 | -12.33 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -56.10% | -19.06% |
| ROE (TTM) | -55.66% | 15.70% |
| Net Profit Margin (TTM) | -4,365.35% | -813.88% |
| ROIC 5YR AVG | -84.56% | 3.12% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.76% | -2,516.13% | -1,513.96% |
| Revenue | -63.77% | -10.40% | -30.43% |
| Net Income | 3.35% | -1,977.15% | -1,192.14% |
| Cash Flow | 3.55% | -177.49% | -124.25% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.79 | 5.56 |
| Quick Ratio (TTM) | 7.79 | 5.34 |
| D/E Ratio (TTM) | N/A | 0.95 |
| Interest Coverage (TTM) | -39.76 | -6.44 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | N/A | 12.45 |
| LTL to 5YR AVG FCF | N/A | 0.11 |
| Shares Outstanding Growth 5YR AVG | 6.60% | 37.46% |